La Dott.ssa Nichakorn Seehirunwong è un medico radiologo diagnostico presso l'Intrarat Hospital di Bangkok. È specializzata nell'interpretazione dei risultati di diagnostica per immagini e nella definizione di piani terapeutici complessi. La Dott.ssa Seehirunwong ha conseguito la laurea in medicina presso la Prince of Songkla University. Presso lo stesso istituto ha inoltre completato la specializzazione in radiologia diagnostica.
Il Dr. Yusuf Acikgoz è un oncologo medico presso l'ospedale universitario Lokman Hekim di Ankara. È specializzato nel trattamento di tumori complessi, tra cui neoplasie maligne del polmone, della mammella e del fegato. Ha completato un fellowship presso la Ohio State University negli Stati Uniti. Il Dr. Acikgoz gestisce trattamenti come chemioterapia, radioembolizzazione e immunoterapia.
Il Dr. Ramazan Uyar è un neurochirurgo presso il complesso ospedaliero Medical Park Antalya. È specializzato in chirurgia degli aneurismi e rimozione di tumori del midollo spinale. Il Dr. Uyar ha vinto il premio per la tesi Dr. Cengiz Çetin dell'Ordine dei Medici di Istanbul. Tratta una vasta gamma di patologie neurologiche pediatriche e adulte.
Il Dr. Serdal Gungor è un neurochirurgo pediatrico presso il complesso ospedaliero Medical Park Antalya. Si concentra sul trattamento di patologie complesse del cervello e della colonna vertebrale nei bambini. Il Dr. Gungor ha completato la sua formazione specialistica presso la prestigiosa Università Hacettepe. Esegue procedure complesse come la rimozione di tumori cerebrali, la chirurgia dell'epilessia e il posizionamento di shunt.
Il Dr. Ibrahim Bayar Cinar è un chirurgo cardiovascolare presso l'ospedale Medical Park Bahcelievler di Istanbul. È specializzato nel trattamento del prolasso della valvola mitrale e dell'insufficienza della valvola aortica. Il Dr. Cinar ha completato una fellowship clinica presso l'University of Ottawa Heart Center in Canada. È membro della Società Europea di Chirurgia Cardiovascolare e Chirurgia Vascolare.
Il Dr. Erkan Kaptanoglu è un neurochirurgo presso la clinica Estexper di Istanbul. È specializzato in chirurgia complessa della colonna vertebrale, neurochirurgia pediatrica e resezione di tumori cerebrali. Il Dr. Kaptanoglu ha vinto il primo premio agli Acibadem Hospital Medical Research Awards. Ha completato una borsa di ricerca sulla rigenerazione del midollo spinale presso l'Università di Toronto.
Guarda il portfolio
Il Dr. Tuncay Kaner è un neurochirurgo spinale presso l'ospedale Medical Park Bahcelievler. Ha completato una fellowship presso l'UCLA Santa Monica Comprehensive Spine Center. Il Dr. Kaner è un membro attivo della Scoliosis Research Society (SRS). È inoltre membro di AO Spine International. Presta servizio presso un ospedale universitario accreditato JCI a Istanbul.
Il Dr. Evren Sandal è un neurochirurgo presso il Medicalpoint International Hospital di Smirne. È specializzato in chirurgia della base cranica, neurochirurgia vascolare e chirurgia della giunzione cranio-cervicale. Il Dr. Sandal ha completato ricerche mirate sulla chirurgia di bypass cerebrale presso l'Università del Wisconsin, USA. Tratta patologie complesse, inclusi tumori cerebrali, stenosi spinale e cisti cerebrali.
Il Dr. Hasan Mutlu è un oncologo medico presso il complesso ospedaliero Medical Park Antalya. È specializzato in immunoterapia, terapie oncologiche mirate e ricerca genetica nel trattamento del cancro. Il Dr. Mutlu ha conseguito la laurea in medicina presso l'Università Hacettepe. Detiene il titolo di Professore di Medicina. Il Dr. Mutlu si concentra sulla diagnosi dei tumori d'organo e sulla chemioterapia.
Il Dr. Mustafa Serkan Alemdar è un oncologo clinico presso il complesso ospedaliero Medical Park Antalya. È specializzato nel trattamento di tumori solidi complessi e tumori del sangue. Il Dr. Alemdar ha conseguito la laurea in medicina e ha completato la specializzazione in oncologia presso l'Università di Akdeniz. È un membro attivo della Società Turca di Oncologia Medica.
Il Dr. Ali Osman Mucuoglu è un neurochirurgo presso l'Ospedale Universitario Atlas di Istanbul. È specializzato nella rimozione di tumori cerebrali e nella chirurgia mininvasiva delle emorragie intracerebrali. Il Dr. Mucuoglu ha utilizzato la tecnologia di stampa 3D per l'ipofisectomia transfenoidale assistita. È membro dell'Associazione Europea delle Società di Neurochirurgia.
Il Dr. Muhammed Mustafa Atci è professore associato di Oncologia Medica presso il Liv Hospital Topkapı. È specializzato nel trattamento dei tumori al colon, al seno, allo stomaco e ai polmoni. In precedenza ha ricoperto il ruolo di coordinatore della formazione presso l'Ospedale Cittadino Prof. Dr. Cemil Taşcıoğlu. Il Dr. Atci è membro dell'American Society of Clinical Oncology (ASCO).
Il Dr. Lee Sanggu, MD, PhD, è un neurochirurgo. È Direttore Medico Onorario e Direttore del Centro della Colonna Vertebrale. È anche Professore di Neurochirurgia presso il Gachon University Gil Medical Center.
L'attenzione clinica include tumori spinali, disturbi della colonna vertebrale, chirurgia spinale mininvasiva e disturbi cervicali. Le procedure includono PEN, PNP, blocco nervoso selettivo, discectomia microscopica o endoscopica, sostituzione del disco artificiale, fusione spinale mininvasiva e vertebroplastica.
Ha conseguito un dottorato di ricerca in Medicina presso l'Università di Hanyang. Ha servito come Capo della Neurochirurgia presso il Veterans Health Service Medical Center. È membro del consiglio esecutivo di KNS, KNTS e KSNS. Ha servito come Vicepresidente e Presidente della KSCS. È un ex presidente di KOMISS, KAME e KSPNS. È membro del comitato Asia-Pacifico di AOSpine e membro a pieno titolo della NASS. È stato inserito nel Marquis Who’s Who nel 2010.
Il Dr. Mehmet Hakan Şahin è un neurochirurgo presso l'Atlas University Hospital (al 2026). È specializzato in chirurgia neuro-oncologica e neurovascolare. Si occupa inoltre di chirurgia della base cranica, chirurgia cranica complessa e chirurgia spinale. È stato Professore Associato presso l'Università Atatürk (2019–2024) e ha prestato servizio presso UW Health (2024–2025).
È autore di 29 articoli internazionali sottoposti a revisione paritaria e 11 articoli nazionali. Ha scritto 5 capitoli di libri di testo. Ha tenuto 7 presentazioni orali, tra cui all'AANS 2025 e in un panel del 2024 sulla resezione sopratotale dei gliomi. Tra i suoi riconoscimenti figurano il Premio di Incentivazione per Giovani Neurochirurghi della Società Turca di Neurochirurgia (Secondo Premio) nel 2024 e il 1° Premio alla 1ª Yaşargil Microneurosurgery Academy. Detiene il Certificato di Qualificazione in Neurochirurgia Turca (2023). È membro della Società Turca di Neurochirurgia dal 2017 (n. 1620).
Il Dr. Han Yeongmin è un neurochirurgo (MD, PhD). È Direttore Medico e Direttore del Centro di Neurochirurgia presso l'Incheon St. Mary’s Hospital. Tratta malattie cerebrovascolari e disturbi dei nervi periferici. È inoltre specializzato in tumori cerebrali e chirurgia della base cranica. Le patologie trattate includono ictus, emorragia cerebrale, infarto cerebrale e malattia di moyamoya. Esegue interventi di PEN, PNP e SNB. Offre inoltre discectomia microscopica ed endoscopica, sostituzione di disco artificiale, MIS-TLIF/fusione spinale mininvasiva e vertebroplastica.
Ha conseguito il titolo di MD e PhD presso l'Università Cattolica della Corea. È stato professore ospite in chirurgia cerebrovascolare e della base cranica presso il Barrow Neurological Institute (Phoenix, Arizona, USA). Ha inoltre lavorato presso l'Harborview Medical Center, University of Washington (Seattle, USA).
Le sue pubblicazioni includono la co-autorialità del Capitolo 52 del Textbook of Korean Cerebrovascular Surgery. È anche co-autore di Acoustic Neuroma Oncology. È membro a pieno titolo di KNS, KSCVS, KSBS, KBTS, KNTS, KSNS e KSPNS.
Il Dr. Halil Can è Professore di Neurochirurgia presso l'İstinye University Liv Hospital Topkapı. È specializzato in chirurgia endoscopica e microchirurgica della colonna vertebrale per tumori e malattie degenerative. Il Dr. Can è autore di 21 pubblicazioni internazionali sottoposte a revisione paritaria. Esegue procedure complesse, tra cui la chirurgia endoscopica della base cranica e dell'ipofisi.
Il Dr. Irfan Cicin è professore di Oncologia Medica presso l'ospedale İstinye University Liv Topkapı. È specializzato nel trattamento di tumori complessi, tra cui glioblastoma, cancro ai polmoni e tumori pancreatici. È professore presso la Facoltà di Medicina dell'Università di Trakya. Il Dr. Cicin ha precedentemente prestato servizio come medico nell'Aeronautica Militare Turca.
Il Dr. Ali Ihsan Anadolulu è un chirurgo specialista presso il Central Hospital di Istanbul. Si concentra sulla chirurgia gastrointestinale pediatrica e sulle malformazioni anorettali. Il Dr. Anadolulu tratta disturbi colorettali e del pavimento pelvico complessi nei bambini. Utilizza tecniche mininvasive per i casi di chirurgia pediatrica.
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.